EMA odporučila schválenie nového lieku Rasonque na metastatickú rakovinu pankreasu
Safety Classified by Officially
Liek má potenciál zaradiť sa medzi prelomové terapie.
This is an extract. The publication continues at the source.
Read the original at the source: https://www.sukl.sk/pre-verejnost-pacientov-a-media/pre-media/tlacove-spravy/ema-odporucila-schvalenie-noveho-lieku-rasonque-na-metastaticku-rakovinu-pankreasu
Officially imported this from ŠÚKL (Štátny ústav pre kontrolu liečiv)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- ŠÚKL (Štátny ústav pre kontrolu liečiv) — imported from official source
- Official source
- https://www.sukl.sk/sk/rss?page_id=1355&days=365 RSS
- Imported
- October 20, 2026 12:02
- Versions
- 1 recorded
- Identity
-
https://www.sukl.sk/pre-verejnost-pacientov-a-media/pre-media/tlacove-spravy/ema-odporu...